Live Breaking News & Updates on Daiichi Sankyo Ltd

Stay updated with breaking news from Daiichi sankyo ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor

On Friday, the FDA approved Daiichi Sankyo Ltd’s (OTC:DSKYF) (OTC:DSNKY) and AstraZeneca Plc’s (NASDAQ:AZN) Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. This indication is approved under accelerated approval based on objective response rate (ORR) and duration of response (DOR). Continued approval for this indicat ....

Ken Keller , Wikimedia Commons , Daiichi Sankyo Ltd , Daiichi Sankyo Inc , Astrazeneca Plc , New Hope , Aggressive Lung Cancer , Imfinzi Shows Promising Results , Global Head , Oncology Business , Daiichi Sankyo , Stock Market Game , Benzinga Pro , Day Trial , Flagship Drug Enhertu Secures Accelerated ,